The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma

SIMPLE SUMMARY: In this study, we investigated the associations of circulating tumor DNA (ctDNA), measured at a random time point during the patient’s treatment, with tumor progression and routine blood markers (protein S100, lactate dehydrogenase (LDH), and C-reactive protein (CRP)) in a cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: Boerlin, Aurelio, Bellini, Elisa, Turko, Patrick, Cheng, Phil F., Levesque, Mitchell P., Dummer, Reinhard, Ramelyte, Egle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455041/
https://www.ncbi.nlm.nih.gov/pubmed/36077695
http://dx.doi.org/10.3390/cancers14174158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455041/
https://www.ncbi.nlm.nih.gov/pubmed/36077695
http://dx.doi.org/10.3390/cancers14174158

Ejemplares similares